The healthcare sector is experiencing a paradigm shift, brought forth by the CMS-HCC Model V28's emphasis on clinical specificity. This shift isn't merely a regulatory update but a redefinition of how healthcare organizations approach risk adjustment, documentation, and coding processes.
The biopharmaceutical sector is currently experiencing a dynamic phase marked by regulatory reforms, technological growth, and strategic corporate actions. This environment presents both challenges and opportunities for industry players, prompting adaptive strategies to thrive in an evolving
In the challenging landscape of healthcare, where numerous pressures such as rising costs and staff burnout persist, the Centers for Medicare & Medicaid Services (CMS) have announced a formidable shift. With the upcoming mandate of the Transforming Episode Accountability Model (TEAM), starting
Faisal Zain is an acclaimed expert in the healthcare technology sphere, known for his groundbreaking work in the innovation and manufacturing of medical devices aimed at enhancing diagnostic and treatment processes. Today, we delve into the dynamics shaping the digital health sector in 2025,
UnitedHealth Group stands as a giant in the healthcare industry, with its expansive reach now encompassing 2,694 subsidiaries and affiliates. The enormity of this growth has sparked discussions about whether the corporation has ventured beyond its own managerial capability. As the complexities of
Faisal Zain, a seasoned expert in healthcare technology, brings profound insights into the realm of medical devices and technology-driven transformations within the healthcare sector. Today, he shares his perspectives on symplr's recent strategic acquisition of AMN Healthcare's Smart
